Supplement NDI Notification Guidance Cruel To Firms On Animal Testing

CFSAN’s latest draft guidance for NDI notifications does little to address the supplement industry’s concerns, and the “worst” aspect is a recommendation to test ingredients on animals when historical use data is not available, says a New Hope Network analyst.

The recommendations on animal testing in FDA's revised draft guidance for new dietary ingredient notifications offends nutritional supplement firms and their customers, says Todd Runestad, a New Hope Network analyst.

At the Natural Products Expo East trade show in Baltimore on Sept. 21, Runestad said the revised draft differs little...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from United States

More from North America